CPT: Pharmacometrics & Systems Pharmacology Erfahrungen und Bewertung

CPT: Pharmacometrics & Systems Pharmacology Erfahrungen und Bewertung

Veröffentlicht von on 2017-01-25

🏷️ Über: CPT: Pharmacometrics & Systems Pharmacology is now available on your iPad and iPhone. Fresh from the newsstand, the open access sibling journal to the well-established high impact journal, Clinical Pharmacology & Therapeutics, brings you a cross-disciplinary journal devoted to publishing advances in quantitative methods as applied in pharmacology, physiology and therapeutics in humans.


       




Lesen Sie 0 Kundenservice Bewertungen 👿🤬😡😠💢😤


Wie war Ihre Erfahrung mit CPT: Pharmacometrics & Systems Pharmacology? Schreiben Sie eine Rezension




Funktionen

The journal welcomes original research articles, reviews and tutorials that bridge the following areas: pharmacometrics, modeling and simulation as applied to the design and evaluation of clinical trials, systems pharmacology modeling, particularly with a mechanistic link to human (patho)physiology, disease modeling, “population” or mixed-effects pharmacokinetics and pharmacodynamics (PKPD) modeling, modeling and simulation to support translational research, physiologically-based pharmacokinetics (PBPK), model-based meta-analyses of clinical trials, mechanism-based pharmacokinetic-pharmacodynamic modeling, computational pharmacology, bioinformatics, comparative efficacy, effectiveness and cost-effectiveness.

CPT: Pharmacometrics & Systems Pharmacology is a cross-disciplinary journal devoted to publishing advances in quantitative (e.g. modeling and simulation) methods as applied in pharmacology, physiology and therapeutics in humans.

Fresh from the newsstand, the open access sibling journal to the well-established high impact journal, Clinical Pharmacology & Therapeutics, brings you a cross-disciplinary journal devoted to publishing advances in quantitative methods as applied in pharmacology, physiology and therapeutics in humans.

CPT: Pharmacometrics & Systems Pharmacology is now available on your iPad and iPhone.